BioNexus Gene Lab (BGLC) Inventory (2018 - 2026)

BioNexus Gene Lab (BGLC) has 9 years of Inventory data on file, last reported at $667154.0 in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 43.42% year-over-year to $667154.0; the trailing twelve-month figure through Mar 2026 stood at $667154.0 (down 43.42% YoY), and the FY2025 full-year result was $676703.0, down 51.27% from the prior year.
• Inventory eased to $667154.0 in Q1 2026, from $676703.0 in the prior quarter.
• In the past five years, Inventory ranged from a high of $1.6 million in Q1 2022 to a low of $667154.0 in Q1 2026.
• A 5-year average of $1.1 million and a median of $1.1 million in 2023 frame the typical range for Inventory.
• Across the five-year window, Inventory advanced 25.38% in 2024 and slumped 51.27% in 2025, its largest moves.
• Tracing BGLC's Inventory over 5 years: stood at $977807.0 in 2022, then climbed by 16.36% to $1.1 million in 2023, then rose by 22.05% to $1.4 million in 2024, then tumbled by 51.27% to $676703.0 in 2025, then decreased by 1.41% to $667154.0 in 2026.
• Business Quant data shows BGLC's Inventory at $667154.0 in Q1 2026, $676703.0 in Q4 2025, and $1.0 million in Q3 2025.